Literature DB >> 22581268

Early identification of leptospirosis as an ignored cause of multiple organ dysfunction syndrome.

Huang-Yu Yang1, Tzung-Hai Yen, Chan-Yu Lin, Yung-Chang Chen, Min-Jeng Pan, Chih-Hsiung Lee, Chun-Chen Yu, Mai-Szu Wu, Shin-Shu Wu, Cheng-Hao Weng, Kwan-Hsing Chen, Cheng-Chieh Hung, Chih-Wei Yang.   

Abstract

Leptospirosis is the most common zoonosis in the world but remains underreported, owing to protean manifestations and ignorance about the disease among health care providers in Taiwan. From September 2000 to March 2006, surveillance of 455 patients with multiple organ dysfunction syndrome with unclear cause or clinical suspicion of leptospirosis was performed. Diagnosis was further confirmed by microscopic agglutination test or isolation of Leptospira. Cases were classified as excluded based on confirmed etiology other than leptospirosis or negative paired serologic test. Forty-two patients were confirmed as having leptospirosis, which accounted for 9.2% of total patients with multiple organ dysfunction syndrome. Forty-nine excluded cases were identified for a case-control analysis for clinical distinction. The most common presentations of leptospirosis were fever (97.6%), acute kidney injury (85.7%), and jaundice (61.9%). The leptospirosis group showed lower urine specific gravity (cutoff value, 1.0145) and enlarged kidney size (cutoff value, 11.05 cm) as compared with the excluded cases by multivariate logistics regression. Delayed antibiotic administration prolongs the duration of hospitalization (R2 = 0.486, P < 0.01). No mortality has been found in the leptospirosis group after initiation in 2003 of rapid immunoglobulin M serology assay that showed considerably high sensitivity and specificity. Leptospirosis accounts for a salient cause of multiple organ dysfunctions in Taiwan. Early awareness of leptospirosis by distinct presentations, followed by prompt antibiotics therapy, can dramatically save the patients. The easily performed rapid immunoglobulin M serology assay is suitable as a rapid screening test for the diagnosis of leptospirosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22581268     DOI: 10.1097/SHK.0b013e3182594ad7

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  8 in total

Review 1.  Going Micro in Leptospirosis Kidney Disease.

Authors:  Wiwat Chancharoenthana; Asada Leelahavanichkul; Marcus J Schultz; Arjen M Dondorp
Journal:  Cells       Date:  2022-02-16       Impact factor: 6.600

2.  Human leptospirosis trends: northeast Thailand, 2001-2012.

Authors:  Wilawan Thipmontree; Yupin Suputtamongkol; Wiwit Tantibhedhyangkul; Chuanpit Suttinont; Ekkarat Wongswat; Saowaluk Silpasakorn
Journal:  Int J Environ Res Public Health       Date:  2014-08-20       Impact factor: 3.390

3.  Live imaging of bioluminescent leptospira interrogans in mice reveals renal colonization as a stealth escape from the blood defenses and antibiotics.

Authors:  Gwenn Ratet; Frédéric J Veyrier; Martine Fanton d'Andon; Xavier Kammerscheit; Marie-Anne Nicola; Mathieu Picardeau; Ivo G Boneca; Catherine Werts
Journal:  PLoS Negl Trop Dis       Date:  2014-12-04

4.  Age-specific epidemiology of human leptospirosis in New Caledonia, 2006-2016.

Authors:  Elise Klement-Frutos; Arnaud Tarantola; Ann-Claire Gourinat; Ludovic Floury; Cyrille Goarant
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

5.  Determinants of prolonged hospitalization and mortality among leptospirosis patients attending tertiary care hospitals in northeastern state in peninsular Malaysia: A cross sectional retrospective analysis.

Authors:  Yassin K Al Hariri; Syed A S Sulaiman; Amer H Khan; Azreen S Adnan; Sundos Q Al-Ebrahem
Journal:  Front Med (Lausanne)       Date:  2022-09-09

6.  Overlooked Risk for Chronic Kidney Disease after Leptospiral Infection: A Population-Based Survey and Epidemiological Cohort Evidence.

Authors:  Huang-Yu Yang; Cheng-Chieh Hung; Su-Hsun Liu; Yi-Gen Guo; Yung-Chang Chen; Yi-Ching Ko; Chiung-Tseng Huang; Li-Fang Chou; Ya-Chung Tian; Ming-Yang Chang; Hsiang-Hao Hsu; Ming-Yen Lin; Shang-Jyh Hwang; Chih-Wei Yang
Journal:  PLoS Negl Trop Dis       Date:  2015-10-09

7.  Urine Levels of Defensin α1 Reflect Kidney Injury in Leptospirosis Patients.

Authors:  Haorile Chagan-Yasutan; Yue Chen; Talitha Lea Lacuesta; Prisca Susan A Leano; Hiroko Iwasaki; Firmanto Hanan; Delsi Taurustiati; Yasukazu Ohmoto; Yugo Ashino; Hiroki Saitoh; Hideyasu Kiyomoto; Yasuhiko Suzuki; Freda O Elizabeth Telan; Toshio Hattori
Journal:  Int J Mol Sci       Date:  2016-09-27       Impact factor: 5.923

8.  Leptospiral 3-hydroxyacyl-CoA dehydrogenase as an early urinary biomarker of leptospirosis.

Authors:  Claudia Toma; Nobuo Koizumi; Tetsuya Kakita; Takayoshi Yamaguchi; Idam Hermawan; Naomi Higa; Tetsu Yamashiro
Journal:  Heliyon       Date:  2018-04-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.